ARCHIVES

FDA cancer therapeutics review split among three units in reorganization.

This article is from The Cancer Letter archive.

Vol. 29 No. 37 | October 10, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Hellman to Leave Memorial This Fall For Position As Dean, Vice President at Univ. Of Chicago

April 8, 1988

NCI Launches $18M Program to Encourage Produce Consumption

July 17, 1992

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009

ACCC To Take In State Chapters, Forms Trials Group

April 6, 1990

James Abbruzzese Moves to Duke Cancer Institute

September 27, 2013

NCI CTEP Approved Trials For the Month of January

January 25, 2013